SRXHA rare “less bad” quarter
SRx Health Solutions said its fiscal second quarter 2026 ended March 31st, and management is trying to frame it as an inflection point. The company says revenue rose 23% quarter over quarter, while its adjusted EBITDA loss improved 44%. In plain English: the business is still in the messy middle, but the trend line is moving in the right direction.
The balance sheet got a little less sweaty
The company also said it finished the quarter with $20.5 million in cash. That matters because for small-cap names, liquidity is basically oxygen — and nobody wants to watch a turnaround story run out of air halfway up the hill. A stronger working-capital position gives SRx more room to keep operating, invest, and maybe avoid the kind of financing moves that make shareholders wince.
A crypto detour, because apparently why not
SRx also highlighted its active cryptocurrency strategy, saying it outperformed the market by 6% and reduced losses by 23% versus a buy-and-hold approach. That’s a little bit hedge-fund-meets-side-quest, and it may catch investor attention whether you love it or side-eye it.
Why investors should care
The stock’s story here isn’t just the quarter itself — it’s whether these improvements are real enough to keep going. If SRx can keep growing revenue, trim losses, and protect liquidity, the turnaround pitch gets more believable. If not, this will read like another familiar small-cap tale: nice slide deck, brutal execution.
Big picture: SRx is trying to turn “we survived” into “we’re actually getting somewhere,” and the market will be watching for proof.